While reduced expression or inactivation of other tumour suppressor genes, including PTEN, NF1, ATRX and DAXX, has been associated with specific GBM subtypes, we are not aware of any other wild type gene that behaves as a tumour suppressor in some GBM subtypes and as an oncogene in others. This evidence concerns the gene PTEN and neoplasm.